In an attempt to develop a new pharmacological strategy against HCC metastasis based on our findings, we focused on inhibitors targeting Rac1 because CAMSAP2 inhibitors are currently not available. This evidence concerns the gene CAMSAP2 and hepatocellular carcinoma.